Pfizer responded to Interface News on November 14th, stating, "We do not comment on the recent rumors and debunking emails regarding the sale of business units Previously, according to reports citing ...

On the morning of October 18th, Hong Kong biopharmaceutical stocks strengthened, with Zaiding Pharmaceutical rising over 12%, WuXi AppTec rising over 7%, Kangnuo and Nuocheng Jianhua rising over 6%, ...

On August 27, PfizerForAll.com, a user friendly platform launched by Pfizer, allows American users to make an appointment for vaccination or have a virtual meeting with doctors, who can prescribe dru ...

Pfizer plans to launch a direct consumer drug platform. On May 13th, Pfizer plans to place the Pfizer for All brand on a direct consumer drug platform. According to a document from the US Patent and ...

Securities Times e-Company News: Novartis Pharmaceuticals rose over 150% in the US stock market, and the company has reached a billion dollar partnership with Sanofi.

Novartis Pharmaceuticals rose over 200% in the US stock market, and the company has reached a multi billion dollar partnership with Sanofi.

Zaiding Pharmaceutical's US stock rose more than 20% before trading, closing at $19.89; The H-share market surged by over 20.8% today, closing at HKD 15.9.

Recently, multinational pharmaceutical giant Novartis announced an agreement to acquire Sinovac Pharmaceuticals, strengthening its presence in the field of kidney disease. Xinruinuo Pharmaceuticals i ...